Sign in

CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
460920988
Phone
805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$40,883
in 1 filing

Net +$959,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing
  2. Nguyen AnhCo −$41K President and CEO sold 4% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-08 HEIDEN WILLIAM K Director Grant or award +11,000 31,500
2021-06-08 HEIDEN WILLIAM K Director Grant or award · Non-Qualified Stock Option (Right to Buy) +17,500 17,500
2021-06-08 Renaud Ronald C JR Director Grant or award +11,000 11,000
2021-06-08 Renaud Ronald C JR Director Grant or award · Non-Qualified Stock Option (Right to Buy) +17,500 17,500
2021-06-08 Roncarolo Maria Grazia Director Grant or award +11,000 11,000
2021-06-08 Roncarolo Maria Grazia Director Grant or award · Non-Qualified Stock Option (Right to Buy) +17,500 17,500
2021-06-08 Gallagher Carol Giltner Director Grant or award +11,000 111,818
2021-06-08 Gallagher Carol Giltner Director Grant or award · Non-Qualified Stock Option (Right to Buy) +17,500 17,500
2021-06-08 DOBMEIER ERIC Director Grant or award +11,000 39,000
2021-06-08 DOBMEIER ERIC Director Grant or award · Non-Qualified Stock Option (Right to Buy) +17,500 17,500
2021-06-08 Fust Matthew K Director Grant or award +11,000 44,854
2021-06-08 Fust Matthew K Director Grant or award · Non-Qualified Stock Option (Right to Buy) +17,500 17,500
2021-06-08 Baynes Roy D. Director Grant or award +11,000 23,000
2021-06-08 Baynes Roy D. Director Grant or award · Non-Qualified Stock Option (Right to Buy) +17,500 17,500
2021-05-18 Newell Joe Chief Operations Officer Sale −2,453 $14.55 $36K 128,971
2021-05-18 Dupont Jakob EVP, Head of R&D Sale −5,184 $14.55 $75K 94,945
2021-05-18 Murugan Amar SVP, GC & Secretary Sale −5,681 $14.55 $83K 91,744
2021-05-18 Touchon Pascal President and CEO Sale −8,313 $14.55 $121K 359,308
2021-05-18 Koppikar Utpal Chief Financial Officer Sale −3,616 $14.55 $53K 168,966
2021-05-18 Yarema Kristin Chief Commercial Officer Sale −761 $14.55 $11K 91,528

Page 14 of 17 · 334 trades